Natera Announces Agreement with One Lambda to Co-Distribute Its Kidney Transplant Rejection Test

SAN CARLOS, Calif., Feb. 1, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of cell-free DNA, today announced a partnership with Thermo Fisher Scientific's One Lambda brand, a global leader in human leukocyte antigen (HLA) typing ...

from PR Newswire: https://prn.to/2S1h50h